EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

World Health Organization classification of tumours of the breast 6th edition 2026

Cecily Quinn iD, Puay Hoon Tan iD, Kimberly H Allison iD, Edi Brogi iD, Sunil R Lakhani iD, Stuart J Schnitt iD, Stephen B Fox iD, Shabnam Jaffer iD, Aysegul Sahin iD, Roberto Salgado iD, Anna Sapino iD, Ernest Kwasi Adjei iD und 17 weitere

Histopathology · 2026-08 · 89 (2) · 199-218

DOI: 10.1111/his.70149 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Histopathology, online erschienen am 21.04.2026. Verfasst von Cecily Quinn und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histopathology, St. Vincent's University Hospital and University College, Dublin, Ireland. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, NCI NIH HHS, Cancer Centre Support Grant of the National Institutes of Health/National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 6th edition of the WHO Classification of Breast Tumours introduces both major and minor changes based on recent advances in our understanding of breast biology, developments in diagnostic modalities, identification of specific molecular targets and new treatment regimens necessitating modifications to pathology reporting and tumour biomarker categorisation. This review summarises the main changes that strive towards a classification of global relevance. In invasive carcinoma, predictive factors increasingly inform modern breast cancer treatment. The 6th edition provides an update on HER2 reporting categories following the DESTINY‐Breast 04 and 06 trials. Terminologies used to classify invasive tumours are clarified, with the term ‘variant’ now reserved for molecular/genetic alterations. Invasive lobular carcinoma (ILC) with extracellular mucin is recognised as a new diagnostic entity with prognostic implications. The diagnosis of mucinous carcinoma (MC) is reserved for mucin secreting carcinomas with grade 1 or 2 morphology and a favourable biomarker profile. The diagnosis of malignant phyllodes tumours requires only four of the original five adverse histological criteria. Classification of neuroendocrine tumours (NETs) is revised, recognising that the unified model, promoted in the 5th edition, is difficult to apply to the breast. New approaches to the classification of adenomyoepithelioma are discussed but the 5th edition system is broadly retained. A new section on ‘Small Diagnostic Samples’ outlines the merits of non‐operative biopsy diagnosis, the B coding system and the importance of multidisciplinary review. Changes to diagnostic practice and the emerging role of artificial intelligence, with advantages and challenges, are discussed in a new section on ‘Digital Pathology’.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleWorld Health OrganizationBiomarkers, Tumor

Stichwörter der Autor:innen

6th editionWHO classification of tumoursbreast tumour classification

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Histopathology, St. Vincent's University Hospital and University College, Dublin, Ireland.
  • Department of Pathology, Luma Medical Centre, Singapore, Singapore.
  • Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Department of Pathology, University of Queensland Centre for Clinical Research, Pathology Queensland and Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia.
  • Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Cecily Quinn, Puay Hoon Tan, Kimberly H Allison, Edi Brogi, Sunil R Lakhani, Stuart J Schnitt, Stephen B Fox, Shabnam Jaffer, Aysegul Sahin, Roberto Salgado, Anna Sapino, Ernest Kwasi Adjei, Katherine Geiersbach, Thomas H Helbich, Matteo Lambertini, Christos Sotiriou, Jennelle C Hodge, Joseph D Khoury, Bharat Rekhi, Ales Ryska, Gary Tse, Andrew Field, Harshima Wijesinghe, Pavitratha Puspanathan, Christine Giesen, Blanca Iciar Indave Ruiz, Ian Ellis, Dilani Lokuhetty

Förderung

  • World Health Organization
  • NCI NIH HHS
  • Cancer Centre Support Grant of the National Institutes of Health/National Cancer Institute

Zitieren

APA

Quinn, C., Tan, P. H., Allison, K. H., Brogi, E., Lakhani, S. R., Schnitt, S. J., Fox, S. B., Jaffer, S., Sahin, A., Salgado, R., Sapino, A., Adjei, E. K., Geiersbach, K., Helbich, T. H., Lambertini, M., Sotiriou, C., Hodge, J. C., Khoury, J. D., Rekhi, B., …, & WCT Standing Editorial Board (2026). World Health Organization classification of tumours of the breast 6th edition 2026. Histopathology, 89(2), 199-218. https://doi.org/10.1111/his.70149

Vancouver

Quinn C, Tan PH, Allison KH, Brogi E, Lakhani SR, Schnitt SJ, et al. World Health Organization classification of tumours of the breast 6th edition 2026. Histopathology. 2026;89(2):199-218. doi:10.1111/his.70149

BibTeX
@article{Quinn2026,
  author = {Quinn, Cecily and Tan, Puay Hoon and Allison, Kimberly H and Brogi, Edi and Lakhani, Sunil R and Schnitt, Stuart J and Fox, Stephen B and Jaffer, Shabnam and Sahin, Aysegul and Salgado, Roberto and Sapino, Anna and Adjei, Ernest Kwasi and Geiersbach, Katherine and Helbich, Thomas H and Lambertini, Matteo and Sotiriou, Christos and Hodge, Jennelle C and Khoury, Joseph D and Rekhi, Bharat and Ryska, Ales and Tse, Gary and Field, Andrew and Wijesinghe, Harshima and Puspanathan, Pavitratha and Giesen, Christine and Ruiz, Blanca Iciar Indave and Ellis, Ian and Lokuhetty, Dilani and WCT Standing Editorial Board, WCT Standing Editorial Board},
  title = {World Health Organization classification of tumours of the breast 6th edition 2026},
  journal = {Histopathology},
  year = {2026},
  volume = {89},
  number = {2},
  pages = {199--218},
  doi = {10.1111/his.70149}
}
Kostenlos starten →